Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Asthma × Fluticasone-Salmeterol Drug Combination × Clear all

Phase

Phase 4 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 2 Pulmonary Disease, Chronic Obstructive 1 Asthma 1

Interventions

fluticasone-formoterol 1 Formoterol Fumarate 1 Fluticasone-Salmeterol Drug Combination 1 Budesonide, Formoterol Fumarate Drug Combination 1 Budesonide 1 Bronchial Thermoplasty 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03387241 2019-04-29

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Unknown

Asthma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡